Switch View
© PR Newswire
29.09.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
AbbVie Announces UK Pricing Strategy for ELAHERE® (mirvetuximab soravtansine-gynx)
News Preview
The list price will be consistent with the United States to reflect the value of the innovation
AbbVie is committed to ensuring that developed nations fully recognize the value of our medicines in improving patient outcomes, consistent...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: JP3801300009
Phc Holdings Corp.
65230
LISTED
XJPX
Epredia’s E1000 Dx Digital Pathology Solution Wins 2025 International Scanner Benchmark Awards from the Ecosystem for Pathology Diagnostics with AI Assistance (EMPAIA)
News Preview
The Ecosystem for Pathology Diagnostics with AI Assistance (EMPAIA), an international organization that advances the use of validated AI solutions in clinical practice, has announced that Epredia, a global leader in precision cancer diagnostics, has won three categories in the 2025 International Scanner Benchmark (ISB) for Epredia’s E1000 Dx Digit...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
29.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Class Action Filed Against Nutex Health Inc. (NUTX) Seeking Recovery for Investors - Contact The Gross Law Firm
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
Shareholders who pur...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
29.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Shareholders of Semler Scientific, Inc. Should Contact The Gross Law Firm Before October 28, 2025 to Discuss Your Rights - SMLR
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR).
Shareholders w...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Shareholders that lost money on Altimmune, Inc.(ALT) should contact The Gross Law Firm about pending Class Action - ALT
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Altimmune, Inc. (NASDAQ: ALT).
Shareholders who purcha...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
The Gross Law Firm Reminds Savara Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2025 - SVRA
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA).
Shareholders who purchased...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Investors in LifeMD, Inc. Should Contact The Gross Law Firm Before October 25, 2025 to Discuss Your Rights - LFMD
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD).
Shareholders who purchase...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
The Gross Law Firm Notifies Shareholders of Lantheus Holdings, Inc.(LNTH) of a Class Action Lawsuit and an Upcoming Deadline
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH).
Shareholders w...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Class Action Filed Against Cytokinetics, Incorporated (CYTK) Seeking Recovery for Investors - Contact The Gross Law Firm
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK).
Shareholder...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Consortium consisting of Nordic Capital and Permira extends offer period until 14 October 2025 and provides update on regulatory approvals in respect of the takeover offer to the shareholders of Bavarian Nordic
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© Newsfile
29.09.2025
ISIN: CA09073K1084
Biomark Diagnostics Inc.
BUX
LISTED
CSE
BioMark Secures Key Patents in Asia's Largest Markets for Early Lung Cancer Liquid Biopsy
News Preview
Pioneering liquid biopsy platform for early lung cancer detection strengthens IP and accelerates commercial strategy in China and Japan diagnostic markets.Vancouver, British Columbia--(Newsfile Corp. - September 29, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy technolog...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
29.09.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Tandem t:slim X2 Insulin Pump Now Compatible With Lyumjev Ultra-Rapid Acting Insulin in the United States
News Preview
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now cleared for use with Eli Lilly and Company’s Lyumjev® (insulin lispro-aabc injection) ultra-rapid acting insulin in the United St...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes
News Preview
GALWAY, Ireland, Sept. 29, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public offering (the "Offering") of €750,000,000 principal amount of 2.950% senior notes due 2030 and €750,000,000 principal...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US22407B1089
Coya Therapeutics, Inc.
COYA
LISTED
NASDAQ
Coya Therapeutics Announces Completion of Patient Enrollment of an Investigator-Initiated, Open-Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Patients with Mild to Moderate Frontotemporal Dementia
News Preview
Following the positive interim results in 5 patients announced earlier this year, a total of 9 patients have been enrolled as planned
The study is progressing according to protocol, and no safety issues have been reported...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA")
News Preview
The APA Formalized the February 2024 BioVaxys Acquisition of the Former IMV Inc. Assets
VANCOUVER, BC, Sept. 29, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce today that the Company and...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA")
News Preview
The APA Formalized the February 2024 BioVaxys Acquisition of the Former IMV Inc. Assets
VANCOUVER, BC, Sept. 29, 2025 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce today that the Company and Horizo...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US0028241000
Abbott Laboratories
ABT
LISTED
NYSE
Abbott's Dissolving Stent Receives Health Canada Approval for Treating Blocked Arteries Below-the-Knee
News Preview
More than 800,000 Canadians1 live with peripheral artery disease (PAD) with limited treatment options to date1
The first-of-its-kind dissolvable stent, the Esprit™ BTK Everolimus Eluting Resorbable Scaffold, dissolves over time after it has opened blocked arteries below-the-knee (BTK)...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
U.S. FDA approves TREMFYA® (guselkumab) for the treatment of pediatric plaque psoriasis and active psoriatic arthritis, marking a first and only approval for an IL-23 inhibitor
News Preview
TREMFYA® is now approved for pediatric patients living with moderate to severe plaque psoriasis, who are candidates for systemic therapy or phototherapy, and active psoriatic arthritis in children six years and older, weighing at least 40 kg
Approval was based...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US7140461093
Revvity Inc
RVTY
LISTED
NYSE
Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis
News Preview
Today Revvity, Inc. (NYSE: RVTY), announced the launch of its Living Image™ Synergy AI multimodal analysis software for in vivo imaging researchers. The solution provides a unified platform with AI capabilities for seamless data analysis across optical, microCT, ultrasound, and other modalities—reducing data inconsistencies, streamlining workflows...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US6323071042
Natera Inc
NTRA
LISTED
NASDAQ
Signatera™ Surveillance Testing Identified 100% of Uterine Cancer Recurrences in Advance of Imaging, New Study Shows
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of a new study in the Journal of Clinical Oncology Precision Oncology (JCO PO), validating Signatera for recurrence monitoring and treatment response assessment in patients with early-stage uterine cancer.
Uterine cancer is the m...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US00846U1016
Agilent Technologies Inc
A
LISTED
NYSE
Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing
News Preview
Agilent Technologies Inc. (NYSE: A) today announced the release of a new range of high performance liquid chromatography (HPLC) columns ideally suited for biotherapeutics applications. The Agilent Altura Ultra Inert HPLC Columns set a new standard in liquid chromatography performance, providing the reliability and efficiency biopharmaceutical comp...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US75901B1070
Regenxbio Inc
RGNX
LISTED
NASDAQ
REGENXBIO Announces Presentation at the World Muscle Society
News Preview
ROCKVILLE, Md., Sept. 29, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced Chief Medical Officer, Steve Pakola, M.D., will present at the International Congress of the World Muscle Society taking place in Vienna, Austria, October 7-11, 2025.
The podium presentation will share new...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Industry Research Finds Two-Thirds of Clinical Data Managers and CRAs Believe Current Inefficiencies Put Data Quality at Future Risk
News Preview
Report shows completing manual data reconciliation, cleaning, and review takes each data manager more than 12 hours per week, per study
BARCELONA, Spain, Sept. 29, 2025 /PRNewswire/ -- Two-thirds of data managers and clinical research associates (CRAs) report th...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Industry Research Finds Two-Thirds of Clinical Data Managers and CRAs Believe Current Inefficiencies Put Data Quality at Future Risk
News Preview
Report shows completing manual data reconciliation, cleaning, and review takes each data manager more than 12 hours per week, per study
BALTIMORE, Sept. 29, 2025 /PRNewswire/ -- SCDM 2025 — Two-thirds of data managers and clinical research associates (CRAs) repo...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US23283X2062
Cytosorbents Corp
CTSO
LISTED
NASDAQ
CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen
News Preview
PRINCETON, N.J., Sept. 29, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced today its strong scientific presence at the upcoming European Association for Cardio-...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US64051A1016
NeOnc Technologies Holdings Inc
NTHI
LISTED
NASDAQ
NeOnc Technologies Appoints Renowned Neuro-Oncologist Dr. Henry S. Friedman to Scientific Advisory Board
News Preview
CALABASAS, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) cancers, today announced it has appointed Dr. Henry S. Friedman to its scientific advisory board. Dr. Friedman is...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US76155X1000
Revolution Medicines Inc
RVMD
LISTED
NASDAQ
Revolution Medicines Announces Key Leadership Additions, including Alan Sandler, M.D. as Chief Development Officer
News Preview
REDWOOD CITY, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the appointment of Alan Sandler, M.D. into the newly created role of chief development officer, as well as the appointment...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: CA74040N1069
Predictmedix AI Inc
PMED
LISTED
CSE
Predictmedix AI to Present at the 25th MK Investment Conference in Munich, Germany
News Preview
Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP0) (“Predictmedix” or the “Company”), an emerging leader in AI-powered health and safety technology, is pleased to announce that its Chief Operating Officer and Co-founder, Dr. Rahul Kushwah, will be presenting at the prestigious 25th MK Investment Conference in Munich, Germany, on October 1,...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: NL0011606264
Merus N.V.
MRUS
LISTED
NASDAQ
MRUS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Merus N.V. Is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Merus N.V. (NASDAQ: MRUS) to Genmab A/S for $97.00 per share is fair to Merus shareholders.
Halper Sadeh encourages Merus shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: IL0011316309
Mediwound Ltd
MDWD
LISTED
NASDAQ
MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares
News Preview
MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US26818M1080
Dyne Therapeutics Inc
DYN
LISTED
NASDAQ
Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy
News Preview
- Data from ongoing DELIVER trial demonstrated sustained functional improvement through 18 months; results from Registrational Expansion Cohort expected late 2025 -...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US09073N3008
Streamex Exchange Corp.
STEX
LISTED
NASDAQ
Streamex Corp. to Participate in the Clear Street Disruptive Technology Conference on November 19-20, 2025
News Preview
LOS ANGELES, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a leader in institutional-grade tokenization of real-world assets, today announced the executive management team, will participate in one-to-one meetings at the Clear Street Disruptive Technology Conference at The Four Seasons Resort in Pa...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US21900C3088
CorMedix Inc
CRMD
LISTED
NASDAQ
CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO
News Preview
- Enrollment Completed in Ongoing Phase III ReSPECT Study in Prophylaxis of Fungal Infections in Adult Patients Undergoing Allogeneic Blood and Marrow Transplant -...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US29251M1062
Enanta Pharmaceuticals Inc
ENTA
LISTED
NASDAQ
Enanta Pharmaceuticals Reports Positive Topline Results from its Phase 2b Study of Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) in High-Risk Adults
News Preview
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced positive topline data from RSVHR, a Phase 2b, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of zelicapavir in outpat...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Humana Invites Everyone to Get in the Game With Pickleball Pop-Up Events
News Preview
Humana Inc. (NYSE: HUM), a leading health and well-being company, is taking pickleball on the road to celebrate their ongoing commitment to creating experiences that enable health, enhance activity, and foster connectivity.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250929806152/en...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US1374041093
Candel Therapeutics, Inc.
CADL
LISTED
NASDAQ
Candel Therapeutics Presents Phase 3 Clinical Trial of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
News Preview
NEEDHAM, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, presented subgroup analyses focused on the radiation regimen from the Company’s positive phase 3...
Themefolio
Profiler
Peergroup
© Newsfile
29.09.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group's Heal Wellness QSR Announces the Signing of a Franchise Agreement for Midtown Toronto, Ontario
News Preview
Toronto, Ontario--(Newsfile Corp. - September 29, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands is pleased to announce that Heal Wellness has signed a franchise agreement for the Yonge & Sheppard area of midtown Toronto, Ontario. Heal Welln...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US98160J1088
MariMed Inc.
MRMD
LISTED
CSE
MariMed Announces Third Quarter 2025 Earnings Date
News Preview
MariMed will report its third quarter 2025 financial results on November 5, 2025 and conduct its analyst conference call on November 6, 2025, at 8am ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide
News Preview
Seasoned clinical leader to oversee Phase 3 development of pemvidutide in MASH...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025
News Preview
Additional Data from MAPLE-HCM Show Aficamten Significantly Improves Measures of Maximaland Submaximal Exercise Capacity and Recovery Compared to Metoprolol...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US28658R1068
Climb Bio, Inc
CLYM
LISTED
NASDAQ
Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN
News Preview
New preclinical data demonstrate deeper IgA reduction and a longer half-life compared to first-generation anti-APRIL monoclonal antibody...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US03828A1016
Applied Therapeutics Inc
APLT
LISTED
NASDAQ
Applied Therapeutics Provides Update Following Meeting with FDA
News Preview
NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the Company), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that the Company completed a meeting with the U.S. Food and Drug Administration (FDA) to discuss the potential new drug...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
Larimar Therapeutics Announces Positive Data from Ongoing Long-term Open Label Study and Updates to Nomlabofusp Program for Friedreich’s Ataxia
News Preview
BALA CYNWYD, Pa., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced positive 25 mg and 50 mg data from the ongoing long-term open label (OL) study evaluating daily subcutaneous injections of noml...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US56400P2011
MannKind Corporation
MNKD
LISTED
NASDAQ
MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer
News Preview
MannKind appoints Dr. Ajay Ahuja as EVP and Chief Medical Officer...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.09.2025
ISIN: US60785L2079
Modular Medical, Inc.
MODD
LISTED
NASDAQ
Modular Medical Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
News Preview
SAN DIEGO, CA / ACCESS Newswire / September 29, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 billion adult "almost-pumpers" diabetes market, today announced the exercise of certain existing warrants issued in May 202...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.09.2025
ISIN: CA0717341071
Bausch Health Companies Inc
BHC
LISTED
TSX
Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry
News Preview
Designed for dental professionals, OraTalks connects leading voices with insights to spark meaningful dialogue.Nine-episode inaugural season hosted by industry thought leader Melissa K. Turner, BASDH, RDHEP, EFDA, CHO.Candid conversations with leading clinicians on the trends shaping today's dental landscape.Episodes launch on September 29 on major...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Presents New Data From the Phase 3 IMPALA-2 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the European Respiratory Society (ERS) Congress 2025
News Preview
Savara Inc. (the “Company”) (Nasdaq: SVRA), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced additional analyses from its pivotal Phase 3 IMPALA-2 clinical trial of molgramostim in aPAP were presented as poster presentations at the ERS Congress 2025 in Amsterdam, The Netherlands.
ERS 2025 Posters...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.09.2025
ISIN: CA58471K2020
Medicus Pharma Ltd.
MDCX
LISTED
TSX
Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject
News Preview
The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the skin using dissolvable Doxorubicin-containing Microneedle arrays (D-MNA) representing ~$2 billion in potential market opportunityThe Company plans to complete patient recruitment for SKNJCT-003 before the end of Q4 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US3723032062
Genmab A/S
GMAB
LISTED
NASDAQ
Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
News Preview
Genmab A/S (Nasdaq: GMAB) and Merus N.V. (Nasdaq: MRUS) announced today that they have entered into a transaction agreement pursuant to which Genmab intends to acquire all the shares of Merus, a clinical-stage biotechnology company with its late-stage breakthrough therapy asset petosemtamab, which is in Phase 3 development, for USD 97.00 per share...
Themefolio
Profiler
Peergroup
© EQS Newswire
29.09.2025
ISIN: CH0012549785
Sonova Holding AG
SOON
LISTED
SIX
Sonova gewinnt Schweizer Innovations-Ranking
News Preview
Sonova Holding AG
/ Schlagwort(e): Sonstiges
Sonova gewinnt Schweizer Innovations-Ranking
29.09.2025 / 07:00 CET/CEST
Group Media & Investor Release
Stäfa (Schweiz), 29. September 2025 – Zum zweiten Mal in Folge ist Sonova als Nummer 1 unter den SMI-Unternehmen* im jährlichen Innovationsranking geführt, das von den ......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.09.2025
ISIN: CH0012549785
Sonova Holding AG
SOON
LISTED
SIX
Sonova wins Swiss innovation ranking
News Preview
Sonova Holding AG
/ Key word(s): Miscellaneous
Sonova wins Swiss innovation ranking
29.09.2025 / 07:00 CET/CEST
Group Media & Investor Release
Stäfa (Switzerland), September 29, 2025 – For the second consecutive year, Sonova is number one among SMI companies* in the annual innovation ranking compiled by business mag......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.09.2025
ISIN: CH1429326825
Siegfried Holding AG
SFZN
LISTED
SIX
DINAMIQS opens cGMP manufacturing facility for viral vectors
News Preview
Siegfried AG
/ Key word(s): Expansion
DINAMIQS opens cGMP manufacturing facility for viral vectors 29.09.2025 / 06:30 CET/CEST
Media Release
Zofingen, September 29, 2025
DINAMIQS, a Siegfried company (SIX: SFZN), today inaugurated its state-of-the-art cGMP manufacturing facility for viral vectors — the first of its kind in Swi......
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: FR0012882389
Equasens
EQS
LISTED
EURONEXT
EQUASENS : Bilan S1 2025 contrat de liquidité
News Preview
Villers-lès-Nancy, le 29 septembre 2025 - 08h00 (CET)...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: AU000000CUV3
Clinuvel Pharmaceuticals Ltd
CUV
LISTED
ASX
CLINUVEL to advance novel pharmaceutical formulations in preclinical program
News Preview
Next generation sustained-release formulations for a variety of peptides Next generation sustained-release formulations for a variety of peptides...
Themefolio
Profiler
Peergroup
© Newsfile
28.09.2025
ISIN: CA8271242072
Silo Wellness Inc.
SILO
LISTED
CSE
Silo Wellness Submits CSE Listing Statement for Review of Born Defense Proposed Change of Business
News Preview
Eugene, Oregon and Toronto, Ontario--(Newsfile Corp. - September 28, 2025) - Silo Wellness Inc. (CSE: SILO) ("Silo" or the "Company"), to be renamed Born Defense Inc., is pleased to announce that it has submitted its listing statement (the "Listing Statement") with the Canadian Securities Exchange (the "CSE") on September 26, 2025, for review in co...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.09.2025
ISIN: US09062X1037
Biogen Inc
BIIB
LISTED
NASDAQ
“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in China
News Preview
TOKYO and CAMBRIDGE, Mass., Sept. 28, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody “LEQ...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.09.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
Larimar Therapeutics Announces Conference Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia
News Preview
Conference call and webcast on Monday, September 29, 2025 at 8:00 am EDT Conference call and webcast on Monday, September 29, 2025 at 8:00 am EDT...
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US8753721047
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on beh...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
